{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:24:55Z","timestamp":1772555095198,"version":"3.50.1"},"reference-count":11,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Neuroendocrine prostate cancer (NEPC) is a rare and aggressive variant of prostate carcinoma, often associated with atypical metastatic spread and poor prognosis. Brain metastases from NEPC are exceptional and may pose significant diagnostic challenges.<\/jats:p>\n                  <jats:p>\n                    We report the case of a 59-year-old man referred for initial staging of prostate cancer after a transrectal ultrasound-guided biopsy that initially demonstrated poorly differentiated adenocarcinoma. Whole-body [\n                    <jats:sup>18<\/jats:sup>\n                    F]fluorocholine positron emission tomography\/computed tomography (PET\/CT) revealed subcentimetric hypermetabolic foci in the left frontal and left temporal cortex and in the left cerebellar hemisphere, suggestive of brain metastases. Pelvic lymphadenopathy was also identified, with no evidence of bone or other visceral involvement. Subsequent histopathological re-evaluation of the initial biopsy, including extended immunohistochemical analysis, demonstrated a neuroendocrine (small cell) component. The patient underwent stereotactic radiotherapy for the cerebral lesions and localized radiotherapy for the primary prostatic tumor.\n                  <\/jats:p>\n                  <jats:p>\n                    This case underscores the diagnostic value of [\n                    <jats:sup>18<\/jats:sup>\n                    F]fluorocholine PET\/CT in detecting unexpected metastatic sites in neuroendocrine prostate carcinoma. Early identification of central nervous system involvement may have therapeutic and prognostic implications, emphasizing the need for molecular imaging in atypical or aggressive prostate cancer phenotypes.\n                  <\/jats:p>","DOI":"10.3389\/fmed.2026.1722967","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T14:04:56Z","timestamp":1772546696000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Unexpected brain metastases from neuroendocrine prostate cancer detected by [18F]fluorocholine PET\/CT: a case report"],"prefix":"10.3389","volume":"13","author":[{"given":"Yassir","family":"Benameur","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Mohammed V Military Teaching Hospital","place":["Rabat, Morocco"]},{"name":"Faculty of Medicine and Pharmacy, Mohammed V University","place":["Rabat, Morocco"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohcine","family":"Hommadi","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Pharmacy, Mohammed V University","place":["Rabat, Morocco"]},{"name":"Department of Radiotherapy, Mohammed V Military Teaching Hospital","place":["Rabat, Morocco"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar Ait","family":"Sahel","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Mohammed V Military Teaching Hospital","place":["Rabat, Morocco"]},{"name":"Faculty of Medicine and Pharmacy, Mohammed V University","place":["Rabat, Morocco"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salah Nabih","family":"Oueriagli","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Mohammed V Military Teaching Hospital","place":["Rabat, Morocco"]},{"name":"Faculty of Medicine and Pharmacy, Mohammed V University","place":["Rabat, Morocco"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikram","family":"Zahfir","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Mohammed V Military Teaching Hospital","place":["Rabat, Morocco"]},{"name":"Faculty of Medicine and Pharmacy, Mohammed V University","place":["Rabat, Morocco"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meryem","family":"Aboussabr","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Mohammed V Military Teaching Hospital","place":["Rabat, Morocco"]},{"name":"Faculty of Medicine and Pharmacy, Mohammed V University","place":["Rabat, Morocco"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaafar El","family":"Bakkali","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Mohammed V Military Teaching Hospital","place":["Rabat, Morocco"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abderrahim","family":"Doudouh","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Mohammed V Military Teaching Hospital","place":["Rabat, Morocco"]},{"name":"Faculty of Medicine and Pharmacy, Mohammed V University","place":["Rabat, Morocco"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/0090-4295(86)90005-1","article-title":"Parenchymal brain metastases from adenocarcinoma of prostate","volume":"28","author":"Lynes","year":"1986","journal-title":"Urology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/PAS.0b013e318058a96b","article-title":"Small cell carcinoma of the prostate: a morphologic and immunohistochemical study of 95 cases","volume":"32","author":"Wang","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejca.2019.08.011","article-title":"Clinical features of neuroendocrine prostate cancer","volume":"121","author":"Conteduca","year":"2019","journal-title":"Eur J Cancer."},{"key":"B4","doi-asserted-by":"publisher","first-page":"4165","DOI":"10.3390\/jcm11144165","article-title":"Prostate cancer brain metastasis: review of a rare complication with limited treatment options and poor prognosis","volume":"11","author":"Rajeswaran","year":"2022","journal-title":"J Clin Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrurol.2014.21","article-title":"Small cell carcinoma of the prostate","volume":"11","author":"Nadal","year":"2014","journal-title":"Nat Rev Urol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/S0022-5347(17)35302-8","article-title":"Prostate specific antigen and gleason grade: an immunohistochemical study of prostate cancer","volume":"151","author":"Aihara","year":"1994","journal-title":"J Urol."},{"key":"B7","first-page":"96","article-title":"Imaging of prostate cancer with PET\/CT using (18)F-Fluorocholine","volume":"5","author":"Vali","year":"2015","journal-title":"Am J Nucl Med Mol Imaging."},{"key":"B8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.5603\/NMR.2015.0010","article-title":"Brain metastases in patient with prostate cancer found in 18F-choline PET\/CT","volume":"18","author":"Gizewska","year":"2015","journal-title":"Nucl Med Rev Cent East Eur."},{"key":"B9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00259-013-2577-6","article-title":"Isolated cerebellar metastasis from prostate adenocarcinoma diagnosed by 18F-fluorocholine PET\/CT: a rare but not impossible complication","volume":"41","author":"Imperiale","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B10","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11<2301::AID-CNCR18>3.0.CO;2-D","article-title":"Brain metastasis from prostate carcinoma: antemortem recognition and outcome after treatment","volume":"86","author":"McCutcheon","year":"1999","journal-title":"Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1158\/1078-0432.CCR-12-3791","article-title":"Platinum-based chemotherapy for variant castrate-resistant prostate cancer","volume":"19","author":"Aparicio","year":"2013","journal-title":"Clin Cancer Res."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1722967\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T14:04:57Z","timestamp":1772546697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1722967\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":11,"alternative-id":["10.3389\/fmed.2026.1722967"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1722967","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"article-number":"1722967"}}